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While the human genome is constant in an individual 
(except  for  somatic  mutation),  our  second  genome, 
encoded by the human microbiome, varies both within 
and between individuals. The microbiome is the totality 
of microbes that live in and on the human body, and the 
combined genomes of these organisms, the metagenome, 
produces a wealth of gene activity whose impact is largely 
unknown but expected to be significant. Each tissue in 
the body carries the same human genome in its cells, but 
each tissue presents a different habitat to microbes, and 
the  microbial  communities  of  these  habitats  have 
different compositions, and thus different metagenomes. 
The goal of many projects, such as the National Institutes 
of Health Human Microbiome Project [1], is to describe 
these communities, and determine the phenotype-geno-
type relations essential for understanding the role of the 
microbiome in health and disease.
The many past and present metagenomic studies of the 
microbiome generally do not address temporal variation, 
but rely on from one to a few time points for each subject 
or habitat sampled (for example, two to three samplings 
per subject for the Human Microbiome Project [1]). The 
most elaborate longitudinal studies to date have collected 
tens of samples in studies of newborns [2,3] and older 
people [4], or environmental shifts caused by diet [5] or 
antibiotic usage [6,7]. These early studies move the field 
in the needed direction, but await technological improve-
ments before they can become routine elaborate experi-
mental designs. In this issue, Caporaso et al. [8] make 
significant strides toward this realization.
Technical milestones
Caporaso  and  colleagues  sampled  three  body  habitats 
(stool, mouth and palms) from two subjects daily for 6 or 
15 months, collecting hundreds of densely spaced speci-
mens.  To  analyze  these  specimens,  they  used  Illumina 
sequencing  (Illumina,  Inc.,  San  Diego,  CA,  USA)  to 
reduce cost and increase throughput and depth of samp-
ling [9], and the Amazon Elastic Compute Cloud (Amazon 
EC2  [10])  for  low  cost,  high  bandwidth  computational 
resources. Both of these methodologies offer the prospect 
of moving future metagenomic studies from the limited 
sampling  realm  to  the  dense  sampling  that  may  be 
required  to  decipher  the  patterns  of  the  microbiome. 
This experimental design moves the bottleneck upstream 
to  the  sampling  phase.  Taking  full  advantage  of  this 
increased  data  production  and  computation  requires 
more  samples,  and  this  introduces  its  own  cost  and 
logistics challenges.
As another technical sideline of the study, the data were 
a combination of sequences from different regions of the 
16S  rRNA  gene,  produced  with  different  sequencing 
platforms: legacy data from 454 sequencing mixed with 
the Illumina 16S rRNA sequences. Sufficient concordance 
was observed between the data sets to allow the study to 
use the merged collection. There has been a prevailing 
concern that different sequencing methods, read lengths 
and variable regions within 16S rRNA perform differently 
in terms of the taxa they detect, so this result is of high 
interest  for  those  who  wish  to  combine  data  sets  to 
increase the power of studies but are concerned about 
introducing biases or other confounding factors for the 
analysis.
Waxing and waning taxa
The  picture  of  the  microbiome  that  emerges  from  the 
study of Caporaso and colleagues is one of volatility. At 
each  body  site,  there  are  relatively  few  taxa  that  are 
present throughout the entire sampling period. Rather, 
most taxa are classified as either persistent, being detec-
table in many consecutive samplings before disappearing, 
or transient, being found for only short periods of time. 
One has the image of the persistent organisms blooming 
to high numbers, only to retreat until they bloom again. 
All of this is amidst a flux of short-term visitors to the 
community.
Abstract
The first detailed temporal study of the human 
microbiome shows that individual body habitats 
exhibit surprising variation over time yet maintain 
distinguishable community structures.
© 2010 BioMed Central Ltd
The volatile microbiome
George M Weinstock*
RESEARCH HIGHLIGHT
*Correspondence: gweinsto@genome.wustl.edu 
The Genome Institute, 4444 Forest Park Avenue, Campus Box 8501, Washington 
University, St Louis, MO 63108, USA
Weinstock Genome Biology 2011, 12:114 
http://genomebiology.com/2011/12/5/114
© 2011 BioMed Central LtdAnother  interesting  characteristic  is  that  taxa  within 
persistent  and  transient  categories  can  be  different, 
allow  ing these communities to be distinguished. In the 
two  subjects  studied,  the  stool  microbiomes  of  both 
persistent and transient communities had few predomi-
nant taxa: the Clostridia, Bacteroidia and, in one subject, 
Erysipelotrichi.  However,  the  persistent  and  transient 
communities in both subjects could be differentiated by 
the  presence  of  Betaproteobacteria  and  Deltaproteo-
bacteria  in  persistent  communities,  while  transient 
communities uniquely contained Gammaproteobacteria 
and Bacilli. In one subject, Actinobacteria, Epsilonproteo-
bacteria  and  Verrucomicrobia  were  also  unique  to  the 
transient community. The tongue and palms had many 
more predominant taxonomic classes, but none of these 
taxa  clearly  differentiated  persistent  and  transient 
communities consistently across the two subjects.
Despite  this  mercurial  community  structure,  the 
communities of the three different habitats remain distin-
guishable from each other at all times. This suggests that 
the players in each community, and the bounds on their 
abundances and half-lives, are some of the differentiating 
characteristics of each body habitat.
Defining disease microbiomes
It is notable that despite enormous interest and activity in 
human microbiome research, no associations between a 
disease  and  microbial  community  have  been  shown. 
Perhaps  this  will  change  once  temporal  variability  is 
taken into account in experimental design and analysis. 
Caporaso et al. [8] move the field closer to being able to 
discern associations between microbiome structure and 
clinical phenotype by showing that the degree of varia-
tion  over  time  is  significant.  It  seems  likely  that  this 
variation may provide a noise level that could obscure 
correlations. This does introduce a new challenge: how to 
analyze  such  temporally  variable  data  to  find  robust 
relationships.  Perhaps  from  this  study,  or  future  ones 
building on it, the number of specimens, depth of samp-
ling, and frequency and duration of sampling needed to 
improve experimental designs can be deduced.
One of the hopes for making such an association is to pro-
duce  new  diagnostic  approaches  for  microbiome-related 
conditions.  However,  if  long-term  time  series  are 
required for these diagnoses, it will limit their utility. One 
hopes that within this volatile microbiome there are still 
unique and less variable elements to be discovered, and 
that these can be of use for more immediate diagnostic or 
therapeutic techniques.
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